APA

Ernst T., Gruber F. X., Pelz-Ackermann O., Maier J., Pfirrmann M., Müller M. C., Mikkola I., Porkka K., Niederwieser D., Hochhaus A. & Lange T. (20091208). A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib. : Haematologica.

Chicago

Ernst Thomas, Gruber Franz X, Pelz-Ackermann Oliver, Maier Jacqueline, Pfirrmann Markus, Müller Martin C, Mikkola Ingvild, Porkka Kimmo, Niederwieser Dietger, Hochhaus Andreas and Lange Thoralf. 20091208. A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib. : Haematologica.

Harvard

Ernst T., Gruber F. X., Pelz-Ackermann O., Maier J., Pfirrmann M., Müller M. C., Mikkola I., Porkka K., Niederwieser D., Hochhaus A. and Lange T. (20091208). A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib. : Haematologica.

MLA

Ernst Thomas, Gruber Franz X, Pelz-Ackermann Oliver, Maier Jacqueline, Pfirrmann Markus, Müller Martin C, Mikkola Ingvild, Porkka Kimmo, Niederwieser Dietger, Hochhaus Andreas and Lange Thoralf. A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib. : Haematologica. 20091208.